{"category":{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T06:02:37.868Z","updated_at":"2026-09-03T06:02:37.868Z","example":false,"profile_url":"/industries/nanotechnology","is_stub":true,"member_count":8,"member_counts":{"company":8}},"members":[{"listing_type":"company","name":"Invitris","slug":"invitris","tagline":"Creating new protein-based drugs at scale","description":"Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material.\n\nOur killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.\n\nInvitris is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://www.invitris.com/","is_stealth":false,"normalized_domain":"invitris.com","normalized_url_key":"invitris.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b31c6e14e61e0a7e292383c88d7094914a492565.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/invitris","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.invitris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.invitris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Nanotechnology","Drug discovery"],"stage":null,"founded_year":null,"location":"Munich, BY, Germany","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:16.195Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Biotech","Nanotechnology","Drug discovery"],"one_liner_for_search":"Invitris — Creating new protein-based drugs at scale (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): Germany, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:16.195Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:16.195Z","updated_at":"2026-09-03T07:28:16.195Z"}},{"listing_type":"company","name":"Persist AI","slug":"persist-ai","tagline":"Developing long-lasting drug formulations 50% faster","description":"It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.\n\nPersist AI is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://www.persist.ai/","is_stealth":false,"normalized_domain":"persist.ai","normalized_url_key":"persist.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/eeb1e38a6ca6e6061c101deae73f22c28c142596.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/persist-ai","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.persist.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.persist.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Machine Learning","Robotics","Microfluidics","Nanotechnology","Therapeutics"],"stage":null,"founded_year":null,"location":"Sacramento, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:03.785Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Machine Learning","Robotics","Microfluidics","Nanotechnology","Therapeutics"],"one_liner_for_search":"Persist AI — Developing long-lasting drug formulations 50% faster (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Persist AI, Persist AI Formulations Corp","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:03.785Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"},{"kind":"industry","slug":"microfluidics","name":"Microfluidics","note":null,"profile_url":"/industries/microfluidics"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"},{"kind":"industry","slug":"robotics","name":"Robotics","note":null,"profile_url":"/industries/robotics"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:03.785Z","updated_at":"2026-09-03T07:28:03.785Z"}},{"listing_type":"company","name":"Keylika","slug":"keylika","tagline":"Redefining the Standard of Care for Iron Deficiency Anemia","description":"Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. \n\nOur first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.\n\nKeylika is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.keylika.com/","is_stealth":false,"normalized_domain":"keylika.com","normalized_url_key":"keylika.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/bd12fc4dc5d053441f31a9c528579e0d16f3449e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/keylika","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Walnut Creek, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:00:15.920Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology","Therapeutics"],"one_liner_for_search":"Keylika — Redefining the Standard of Care for Iron Deficiency Anemia (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 1","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:00:15.920Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:00:15.920Z","updated_at":"2026-09-03T07:00:15.920Z"}},{"listing_type":"company","name":"Nomic Bio","slug":"nomic-bio","tagline":"Nomic is doing for proteins what Illumina has done for DNA","description":"Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. \n\nToday we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space.\n\nOur goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. \n\nWe're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!\n\nNomic Bio is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.nomic.bio/","is_stealth":false,"normalized_domain":"nomic.bio","normalized_url_key":"nomic.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/d3005075624cbc032b9abdd1525e6ec3201158f5.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nomic-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.nomic.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nomic.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Nanotechnology"],"stage":null,"founded_year":null,"location":"Montreal, QC, Canada","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:32:07.305Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Nanotechnology"],"one_liner_for_search":"Nomic Bio — Nomic is doing for proteins what Illumina has done for DNA (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 24","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: nplex biosciences","Regions (per YC): Canada, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:32:07.305Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:32:07.305Z","updated_at":"2026-09-03T06:32:07.305Z"}},{"listing_type":"company","name":"spotLESS Materials","slug":"spotless-materials","tagline":"Repellent coatings without PFAS","description":"Surface fouling is a costly challenge across industries, impacting medical consumables, diagnostic devices, and automotive components. Contamination from substances like mud, ice, and sludge can compromise performance and lead to frequent cleaning, repairs, and replacements.\n\nOur PFAS-free coating, which we first launched as a consumer product, has quickly expanded into industrial partnerships. It dramatically reduces contamination on critical surfaces such as glass, metal, ceramic, and now plastics too. Whether for medical devices or automotive components, our coating protects against surface fouling\nCurrently our coatings work best on glass, metal, and ceramic surfaces.\n\nspotLESS Materials is a Y Combinator company (Summer 2019). YC-listed status: Active.","url":"https://www.industry.spotlessmaterials.com/","is_stealth":false,"normalized_domain":"industry.spotlessmaterials.com","normalized_url_key":"industry.spotlessmaterials.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/f4bcbe21be5fc35568846a259c348e3973168839.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/spotless-materials","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.industry.spotlessmaterials.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.industry.spotlessmaterials.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Hard Tech","Nanotechnology","Advanced Materials"],"stage":null,"founded_year":null,"location":"State College, PA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:25:08.703Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2019","Hard Tech","Nanotechnology","Advanced Materials"],"one_liner_for_search":"spotLESS Materials — Repellent coatings without PFAS (Y Combinator Summer 2019)","canonical_facts":["Y Combinator batch: Summer 2019","YC company status: Active","Team size (per YC directory): 6","YC industry: Industrials","YC subindustry: Industrials","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:25:08.703Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"advanced-materials","name":"Advanced Materials","note":null,"profile_url":"/industries/advanced-materials"},{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:25:08.703Z","updated_at":"2026-09-03T06:25:08.703Z"}},{"listing_type":"company","name":"Kern Systems","slug":"kern-systems","tagline":"Using DNA to store data.","description":"DNA has emerged as a compelling data storage medium due to its density, longevity, and eternal relevance compared to current memory technologies. However, the high price of synthesizing DNA remains a major bottleneck for adoption of this promising storage solution. We are pioneering new approaches to synthesizing DNA for data storage with enzymes and custom digital codecs. We are building an interdisciplinary team to build the world's most scalable information infrastructure in DNA. \n\nWe seek technical experts in enzyme engineering, chemistry, hardware engineering, and information theory. We also seek business development to identify emerging markets for early use cases of our technology.\n\nKern Systems is a Y Combinator company (Summer 2019). YC-listed status: Active.","url":"https://www.kernsystems.com/","is_stealth":false,"normalized_domain":"kernsystems.com","normalized_url_key":"kernsystems.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/960f475f7529b916c176fbf83565873d60242a91.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kern-systems","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kernsystems.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kernsystems.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:25:07.223Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2019","Genomics","Nanotechnology"],"one_liner_for_search":"Kern Systems — Using DNA to store data. (Y Combinator Summer 2019)","canonical_facts":["Y Combinator batch: Summer 2019","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:25:07.223Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:25:07.223Z","updated_at":"2026-09-03T06:25:07.223Z"}},{"listing_type":"company","name":"Helix Nanotechnologies","slug":"helix-nanotechnologies","tagline":"Next-generation mRNA platform to solve cancer, COVID and climate.","description":"Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button.\n\nBy focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity.\n\nRigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas.\n\nWe've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.\n\nHelix Nanotechnologies is a Y Combinator company (Winter 2017). YC-listed status: Active.","url":"https://www.helixnano.com/","is_stealth":false,"normalized_domain":"helixnano.com","normalized_url_key":"helixnano.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/f05a634de42c2c96484608b63b33b99fd27aa56e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/helix-nanotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.helixnano.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.helixnano.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Artificial Intelligence","Biotech","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; Cambridge, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:07:34.508Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2017","Artificial Intelligence","Biotech","Genomics","Nanotechnology"],"one_liner_for_search":"Helix Nanotechnologies — Next-generation mRNA platform to solve cancer, COVID and climate. (Y Combinator Winter 2017)","canonical_facts":["Y Combinator batch: Winter 2017","YC company status: Active","Team size (per YC directory): 22","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Helix Nanotechnologies","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:07:34.508Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:07:34.508Z","updated_at":"2026-09-03T06:07:34.508Z"}},{"listing_type":"company","name":"Shield Bio","slug":"shield-bio","tagline":"Bringing 3rd generation, nanopore sequencing to healthcare to solve…","description":"Shield Bio is a precision medicine company with a\nproprietary platform that enables reliable nanopore\nsequencing in under a minute, in a clinical setting. It is\nfocused on bringing 3rd generation or \"nanopore\"\nsequencing into clinical use to deliver on the promise of\nprecision medicine. Shield is initially using the technology to\nimprove the treatment of infectious disease and address the\nunmet clinical need of sepsis, which kills 300,000 people a\nyear in the US alone.\n\nShield Bio is a Y Combinator company (Summer 2016). YC-listed status: Inactive.","url":"http://shieldbio.com/","is_stealth":false,"normalized_domain":"shieldbio.com","normalized_url_key":"shieldbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/shield-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"http://shieldbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"http://shieldbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; San Jose, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:02:37.868Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2016","Healthcare","Genomics","Nanotechnology"],"one_liner_for_search":"Shield Bio — Bringing 3rd generation, nanopore sequencing to healthcare to solve… (Y Combinator Summer 2016)","canonical_facts":["Y Combinator batch: Summer 2016","YC company status: Inactive","Team size (per YC directory): 28","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: TL Biolabs, Shield Diagnostics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:02:37.868Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:02:37.868Z","updated_at":"2026-09-03T06:02:37.868Z"}}],"total":8,"limit":50,"offset":0}